Red Light Holland reports an updated position in cash and cash equivalents of roughly CAD$30 million following its merger with Creso Pharma.

Psyched Wellness announces the largest extraction and shipment of its flagship nootropic (AME-1) to Asia.

Field Trip Health has received conditional approval to list on the NASDAQ, symbol “FTRP”.

Levitee Labs announces definitive agreements to acquire 3 specialized pharmacies, a “leading telehealth provider”, and 5 addiction clinics.

A representative of the U.S. Anti-Doping Agency this week shifted blame for the Olympics suspension of U.S. runner Sha’Carri Richardson over a positive marijuana test, saying the national sports organization is “heartbroken” over the case and supports “liberalization” of current bans but claiming that its hands are tied with respect to enforcing international drug policy.

Psyched Wellness wants to bring the Amanita muscaria fungus to the masses.

Mydecine files a new patent application in support of its MDMA-based psychedelic drug research.

A New York senator recently filed a bill to create a provisional marijuana licensing category so that farmers could begin cultivating and selling cannabis ahead of the formal rollout of the adult-use program.

Police at Albany International and other major New York airports are no longer making arrests, writing tickets, or conducting product seizures in the case of low-level cannabis possession by travelers, according to a Times Union report. ​​​​​​​

The psychedelic drug industry represents the best investment opportunity in life sciences of this century. A multitude of opportunities.